Literature DB >> 1643611

Prognostic factors in survival of bladder cancer.

A Lopez-Beltran1, G A Croghan, I Croghan, R P Huben, C Mettlin, J F Gaeta.   

Abstract

Clinical and pathologic data of 36 patients with transitional cell carcinoma of the bladder were investigated to determine the significance on patient survival of these factors: pathologic grade and stage; the immunohistochemistry of eight cell and tumor markers; nuclear DNA flow cytometric parameters; and patient smoking status. The bivariate and multivariate statistical analysis significantly correlated patient survival rates with the immunohistochemical expression of blood group, isoantigens A (P less than 0.05), O(H) (P = 0.001), the oncogene-related protein ORP-p21 (P less than 0.05), the pathologic grade and stage (P = 0.002), and the tumor DNA ploidy (P less than 0.05). Smoking status correlated aneuploidy (P less than 0.05) and tumor expression of ORP-p21 (P less than 0.05) with the patient survival rate. Despite the relatively small number of patients in this study, the results suggest that the clinicopathologic variables are significant factors in survival of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643611     DOI: 10.1002/1097-0142(19920815)70:4<799::aid-cncr2820700414>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma.

Authors:  Ismail Turker Koksal; Mutlu Ates; Ahmet Danisman; Cem Sezer; Akif Ciftcioglu; Gulten Karpuzoglu; Metin Sevuk
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

2.  Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.

Authors:  Kyle B Zuniga; Rebecca E Graff; David B Feiger; Maxwell V Meng; Sima P Porten; Stacey A Kenfield
Journal:  Bladder Cancer       Date:  2020-03-28

3.  Human papillomavirus DNA as a factor determining the survival of bladder cancer patients.

Authors:  A Lopez-Beltran; A L Escudero; L Vicioso; E Muñoz; J C Carrasco
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.